Enzolytics Inc (OTCMKTS:ENZC) Stock Gains 5% In a Week

Investors are often prone to look into stocks which may have clocked gains over a reasonable period of time and hence, it could be a good move to perhaps look into the Enzolytics Inc (OTCMKTS:ENZC) stock today. In the past week, the stock garnered considerable attention and ended up with gains of as much as 5%.

Trading Data

On Wednesday, ENZC stock fell 0.48% to $0.0830 with more than 5.27 million shares traded, compared to its average volume of 12.03 million shares. The stock moved within a range of $0.0810 – 0.0853 after opening trading at $0.0830.

Enzolytics, Inc. Highlights the Introduction of IPF Immune(TM) as CRN Data Shows Record-Breaking Number of Americans Use Dietary Supplements

The company announced yesterday that it was on the verge of launching the IPF Immune product and in order to back up its move, Enzolytics also cited data from CRN. The data was quite positive in nature and could prove to be one of the reasons for the considerable positivity about the stock among investors.

The company noted that at this point in time as much as 80% of Americans use some sort of nutritional supplements and hence, its product could well prove to be a hit in a highly popular market.

In addition to that, there has also been a heightened interest in such supplements which could help with regards to the strengthening immunity in individuals. It is now going to be interesting to see if the stock could in fact hold on to its momentum and further add to its gains.

Key Quote

“The CRN data shows that not only are a record number of Americans using dietary supplements as part of their regular health regimen, but they also increased their use of supplements that help boost their immune system,” said Charles S. Cotropia, CEO of Enzolytics, Inc., a biotech company based in Texas. “We are rolling out Enzolytics IPF Immune™, an immune modulator that supports your immune system.”

Technical Data

ENZC stock is below the 20-Day and 50-Day Moving averages of $0.0838 and $0.0906 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.1332.